Form 4: KORU Medical Systems: CEO Linda Tharby Reports Stock Transactions
Statement of Changes in Beneficial Ownership
KORU Medical Systems CEO Linda Tharby has reported transactions involving common stock, including the acquisition of shares upon vesting of restricted stock units and shares withheld for tax obligations.
Summary
- Linda M. Tharby, CEO and Director of KORU Medical Systems, Inc. (KRMD), filed a Form 4 statement detailing stock transactions.
- On May 14, 2026, 13,977 shares of common stock were acquired upon the vesting of restricted stock units (RSUs). These RSUs represent a contingent right to receive one share of common stock upon vesting.
- Also on May 14, 2026, 7,326 shares were disposed of, representing shares withheld to satisfy tax obligations upon the vesting of RSUs.
- Following these transactions, Tharby beneficially owns 626,757 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it details routine insider stock transactions related to compensation and tax obligations, rather than significant strategic shifts or performance indicators.
Positives
- Acquisition of 13,977 shares of common stock through the vesting of RSUs indicates continued equity participation by the CEO.
- The CEO's direct beneficial ownership of 626,757 shares demonstrates a significant personal stake in the company.
Negatives
- Disposal of 7,326 shares to cover tax obligations, while a standard practice, represents a reduction in the CEO's direct shareholding.
Future Outlook
No specific forward-looking statements or guidance were provided in this Form 4 filing.
Management Comments
- The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company executives and directors. This filing is typical for a publicly traded company like KORU Medical Systems.
Stakeholder Impact
- Shareholders: The filing provides transparency into insider holdings, which can influence investor confidence. The CEO's continued direct ownership is generally viewed positively.
- Employees: Vesting of RSUs for the CEO may align with broader employee equity incentive programs, though specific details for other employees are not provided.
- Management: The transactions reflect standard compensation and tax management practices for executive leadership.
Key Dates
| Date | Description |
|---|---|
| 05/14/2026 | Date of earliest transaction (acquisition and disposal of common stock). |
| 05/19/2026 | Date of signature for the Form 4 filing. |
Keywords
Form 4, SEC Filing, Insider Transaction, KORU Medical Systems, KRMD, Stock Vesting, Restricted Stock Units, Tax Withholding, Beneficial Ownership, CEO, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.